{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T05:48:15Z","timestamp":1769924895699,"version":"3.49.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>\n                           <jats:sup>18<\/jats:sup>F-FDG PET\/CT was performed to evaluate possible recurrent B-cell lymphoblastic lymphoma in a 34-year-old man. The images showed multiple foci of increased activity in the nerve root and peripheral nerve. A biopsy confirmed the diagnosis of neurolymphomatosis. After receiving chemotherapy, PET\/CT showed progressive disease. The patient subsequently received the CD-19 chimeric antigen receptor T-cell therapy. A follow-up PET\/CT acquired 30 days after chimeric antigen receptor T-cell therapy revealed no abnormal FDG activity.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004584","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T23:18:17Z","timestamp":1675120697000},"page":"445-447","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Chimeric Antigen Receptor T-Cell Therapy of Neurolymphomatosis Monitored by FDG PET\/CT"],"prefix":"10.1097","volume":"48","author":[{"given":"Siqi","family":"Li","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongrong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Beijing Boren Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanyun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jigang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/neuonc\/nop021","article-title":"Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab","volume":"12","year":"2010","journal-title":"Neuro Oncol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1182\/blood-2009-12-258210","article-title":"Neurolymphomatosis: an international primary CNS lymphoma collaborative group report","volume":"115","year":"2010","journal-title":"Blood"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12288-015-0526-1","article-title":"Bilateral facial nerve palsy in acute B cell lymphoblastic leukemia: a case report and review of the literature","volume":"32","year":"2016","journal-title":"Indian J Hematol Blood Transfus"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0720-048X(01)00388-6","article-title":"Trigeminal nerve involvement in T-cell acute lymphoblastic leukemia: value of MR imaging","volume":"44","year":"2002","journal-title":"Eur J Radiol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1215\/15228517-5-2-104","article-title":"Neurolymphomatosis","volume":"5","year":"2003","journal-title":"Neuro Oncol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1007\/s00259-006-0112-8","article-title":"Changing PET\/CT manifestation of neurolymphomatosis","volume":"33","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1200\/JCO.2005.05.1003","article-title":"Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma","volume":"24","year":"2006","journal-title":"J Clin Oncol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"7151s","DOI":"10.1158\/1078-0432.CCR-1004-0002","article-title":"Management of central nervous system lymphomas using monoclonal antibodies: challenges and opportunities","volume":"11","year":"2005","journal-title":"Clin Cancer Res"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"102479","DOI":"10.1016\/j.ctrv.2022.102479","article-title":"Toxicities following CAR-T therapy for hematological malignancies","volume":"111","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1097\/RLU.0000000000003340","article-title":"Altered FDG biodistribution in subcutaneous white fat on PET\/CT following l-asparaginase chemotherapy","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1097\/RLU.0000000000002582","article-title":"FDG PET\/CT demonstrated precursor B-cell lymphoblastic lymphoma in a pediatric patient with hemophilia B","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/RLU.0000000000002470","article-title":"Acral involvement of lymphoblastic lymphoma revealed on FDG PET\/CT","volume":"44","year":"2019","journal-title":"Clin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/RLU.0000000000003949","article-title":"Lumbosacral plexus neurolymphomatosis: a typical 18FDG PET\/CT pattern to recognize","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1097\/RLU.0000000000003021","article-title":"PET\/CT in evaluation of low backache due to sacral nerve root involvement: inflammatory and malignant involvement","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib15-20250621","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/RLU.0000000000003756","article-title":"Prognostic impact of 18F-FDG PET\/CT in patients with aggressive B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T cells","volume":"46","year":"2021","journal-title":"Clin Nucl Med"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1097\/RLU.0000000000003870","article-title":"Early 18F-FDG PET flare-up phenomenon after CAR T-cell therapy in lymphoma","volume":"47","year":"2022","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T19:01:59Z","timestamp":1750532519000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004584","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}